Abbott India
ABBOTINDIA · Pharma > Pharmaceuticals & Drugs · Chairman: Munir Shaikh Listing date: Jan. 9, 2010 · Employees: 3585 · Mumbai · http://www.abbott.co.in

Stock Price vs Company Growth
1d
0.9%
1w
0.5%
1m
2.7%
3m
7.5%
6m
12.8%
1y
15.1%
5y
13.3%
10y
19.7%
all
25.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 25,970 0.9%
25,318
28,500
Company Overview

Sales
6,824 Cr
Growth: 9.2%
Profit after Tax
1,524 Cr
Growth: 1.0%
Large Cap
55,184 Cr
P/E: 36.2x
Industry P/E: 28.0x
Fundamentals

Sales (Cr) ₹ 6,824
Growth 9.2%
EBITDA 27.0%
P/S 8.1x
Dividend 1.4%
P/E 36.2x
Book Value ₹ 2,537
PEG Ratio 3.9x
ROE 31.7%
P/B 10.2x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
1.64 %
Promoters
Abbott Capital India Limited
50.44 %
Abbott Healthcare Products Limited
17.62 %
British Colloids Limited
6.92 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India.
Investors (50)
Followers (16)